175 related articles for article (PubMed ID: 10375295)
1. Alendronate increased bone mineral density but did not reduce new fractures in glucocorticoid induced osteoporosis.
Compston JE
Gut; 1999 Jun; 44(6):780-1. PubMed ID: 10375295
[No Abstract] [Full Text] [Related]
2. [Glucocorticoid and bone].
Soen S
Clin Calcium; 2014 Jun; 24(6):829-36. PubMed ID: 24870833
[TBL] [Abstract][Full Text] [Related]
3. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Saag KG; Shane E; Boonen S; Marín F; Donley DW; Taylor KA; Dalsky GP; Marcus R
N Engl J Med; 2007 Nov; 357(20):2028-39. PubMed ID: 18003959
[TBL] [Abstract][Full Text] [Related]
4. Anabolic therapy in glucocorticoid-induced osteoporosis.
Sambrook PN
N Engl J Med; 2007 Nov; 357(20):2084-6. PubMed ID: 18003966
[No Abstract] [Full Text] [Related]
5. Glucocorticoid-induced osteoporosis: treatment options and guidelines.
Maricic M
Curr Osteoporos Rep; 2005 Mar; 3(1):25-9. PubMed ID: 16036098
[TBL] [Abstract][Full Text] [Related]
6. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.
Saag KG; Emkey R; Schnitzer TJ; Brown JP; Hawkins F; Goemaere S; Thamsborg G; Liberman UA; Delmas PD; Malice MP; Czachur M; Daifotis AG
N Engl J Med; 1998 Jul; 339(5):292-9. PubMed ID: 9682041
[TBL] [Abstract][Full Text] [Related]
7. Calcium, vitamin D and etidronate for the prevention and treatment of corticosteroid-induced osteoporosis in patients with rheumatic diseases.
Loddenkemper K; Grauer A; Burmester GR; Buttgereit F
Clin Exp Rheumatol; 2003; 21(1):19-26. PubMed ID: 12673885
[TBL] [Abstract][Full Text] [Related]
8. Alendronate protects premenopausal women from bone loss and fracture associated with high-dose glucocorticoid therapy.
Okada Y; Nawata M; Nakayamada S; Saito K; Tanaka Y
J Rheumatol; 2008 Nov; 35(11):2249-54. PubMed ID: 19031508
[TBL] [Abstract][Full Text] [Related]
9. [Glucocorticoid-induced osteoporosis and bone mineral densimetry].
Tanaka I; Oshima H
Clin Calcium; 2004 Dec; 14(12):77-82. PubMed ID: 15577178
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates and glucocorticoid-induced osteoporosis: implications for patients with respiratory diseases.
Cowan S; Morin S; Ernst P
Thorax; 1998 May; 53(5):331-2. PubMed ID: 9708219
[No Abstract] [Full Text] [Related]
11. Prevention of glucocorticoid-induced osteoporosis.
Saag KG
South Med J; 2004 Jun; 97(6):555-8. PubMed ID: 15255421
[TBL] [Abstract][Full Text] [Related]
12. [Secondary osteoporosis. Evidence of treatment efficacy in patients with glucocorticoid-induced osteoporosis].
Sato S
Clin Calcium; 2007 Apr; 17(4):600-5. PubMed ID: 17404491
[TBL] [Abstract][Full Text] [Related]
13. A cost effectiveness analysis of calcium and vitamin D supplementation, etidronate, and alendronate in the prevention of vertebral fractures in women treated with glucocorticoids.
Buckley LM; Hillner BE
J Rheumatol; 2003 Jan; 30(1):132-8. PubMed ID: 12508402
[TBL] [Abstract][Full Text] [Related]
14. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Rossi CM; Di Comite G
N Engl J Med; 2008 Mar; 358(12):1302; author reply 1303-4. PubMed ID: 18354112
[No Abstract] [Full Text] [Related]
15. Osteoporosis: which current treatments reduce fracture risk?
Baran DT
Cleve Clin J Med; 2000 Oct; 67(10):701-3. PubMed ID: 11060956
[TBL] [Abstract][Full Text] [Related]
16. Prevention and treatment of glucocorticoid-induced osteoporosis in 2005.
Orcel P
Joint Bone Spine; 2005 Dec; 72(6):461-5. PubMed ID: 16326129
[TBL] [Abstract][Full Text] [Related]
17. Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) study.
Tanaka Y; Mori H; Aoki T; Atsumi T; Kawahito Y; Nakayama H; Tohma S; Yamanishi Y; Hasegawa H; Tanimura K; Negoro N; Ueki Y; Kawakami A; Eguchi K; Saito K; Okada Y
J Bone Miner Metab; 2016 Nov; 34(6):646-654. PubMed ID: 26308708
[TBL] [Abstract][Full Text] [Related]
18. Advances in treatment of glucocorticoid-induced osteoporosis.
Hsu E; Nanes M
Curr Opin Endocrinol Diabetes Obes; 2017 Dec; 24(6):411-417. PubMed ID: 28857847
[TBL] [Abstract][Full Text] [Related]
19. Teriparatide or alendronate in glucocorticoid-induced osteoporosis.
Babb RR
N Engl J Med; 2008 Mar; 358(12):1302-3; author reply 1303-4. PubMed ID: 18357641
[No Abstract] [Full Text] [Related]
20. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
De Nijs RN
Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
